Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000683

Type of data
NMR metabolic biomarkers for 1,285 patients from BBJ 1st cohort
Access criteria
Controlled-access (Type I)
Total data volume
240 MB
File formats
  • TXT
  • XLSX
Research
hum0311
Date published
2022-09-27
Date modified
2024-04-25
DDBJ Search
JGAD000683 (opens in a new tab)
JGA Study
JGAS000561 (opens in a new tab)

Unrestricted-access files linked to this dataset

Download the URL list
FileLabelSizeCopy URL
Nightingale_Blood_Biomarker_Analysis_Feb2020.pdfList of metabolites89.2 KB

Analysis method

メタボローム (NMR)

Materials and participants
1,285 + 2,570 + 40,907 patients from BBJ 1st cohort (1,286 + 2,573 + 41,411 samples) Total: 43,830 patients (45,270 samples)
ICD10: R00, I44.0-3, I45.5-6, I47-I49, I70.9, L20, J45, I67.1, I63, G45.9, C50, I50, I21.0-9, H25-H26, C53, B18.1, B18.2, C18-C21, J44.9, L51.1-2, L27.0, E10, E11, E88.8, N80, G40, C15, D25, C23, C24, H40, E05.0, K05, R56.0, C81-C86, C90-C93, C22, J30.1, E78.0-5, E78.8-9, J84.1-9, L91.0, K74.6, C34, N04, M80-M81, C56, C25, A15-A19, C61, M05-M06, I20.1, I20.8, I20.9, C16, N20-N23, I20.0, C54
  • Health status
    Affected
  • Subject count
    43,830 (Individual)
  • Cohort
    BioBank Japan
Sample description
serum samples
  • Tissue
    Serum
Sample provider
N/A
Experimental method
Metabolomics
Target
250 metabolites (List)
Platform
Bruker AVANCE III HD
Normalization
Nightingale Health's proprietary software (quantification library 2020)
Analysis method
Nightingale Health's proprietary software (quantification library 2020)
Data use policy
NBDC data sharing policy (JGAP000001)